Rare diseases
Investigational molecules
Locations
Back to Austria3 clinical trials in Schwaz, Austria. Every trial is listed in the EU Clinical Trials Register and updated daily.
AustriaAustriaAustriaThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on HER2-positive breast cancer treatment, evaluating novel combination therapies with tucatinib, pertuzumab, and trastuzumab for patients with advanced or metastatic disease.
Research aims to measure progression-free survival using established evaluation criteria.
Investigation of elacestrant plus everolimus in treating patients with specific breast cancer subtypes, particularly focusing on those with estrogen receptor-positive and HER2-negative disease.
Double-blind studies examining effectiveness in patients who have progressed after previous treatments.
Advanced research incorporating biomarker-driven approaches in breast cancer treatment, with specific focus on hormone receptor status and genetic mutations.
Studies utilize imaging review committees to ensure accurate assessment of treatment outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
